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ABSTRAK 
 
 Dalam kajian ini, kesan pemberian palm vitamin E (PV), terhadap pengawalan status 
glisemia dan profil lipid pada tikus Sprague Dawley aruhan diabetes telah dikaji.  
Diabetes diaruh menggunakan streptozotocin  secara intravena pada dos 50 mg/kg berat 
badan.  Tikus diabetes dibahagikan kepada dua kumpulan iaitu yang disuplementasi PV 
(200 mg/kg berat badan/hari) setiap hari dan tanpa suplementasi PV (No PV)  Kumpulan 
bukan diabetes (NDM) pula bertindak sebagai kumpulan kawalan.  Selepas suplementasi 
setiap hari selama  lapan minggu, pemberian PV telah berjaya menurunkan aras glukos 
darah puasa (FBG) dan hemoglobin terglikasi (HbA1c) secara signifikan (p<0.01) 
berbanding kumpulan No PV.  Walau bagaimanapun, aras-aras ini masih lebih tinggi 
(p<0.001) berbanding kumpulan kawalan.  Kumpulan suplementasi PV juga telah 
menunjukkan penurunan aras secara signifikan kolesterol total (TC ) dan aras  
lipoprotein berdensiti rendah (LDL-C) (p<0.001) serta  peningkatan aras lipoprotein 
berdensiti tinggi (HDL-C) (p<0.001) secara signifikan berbanding kumpulan No PV.  
Sebagai kesimpulannya, kajian ini mendapati bahawa PV berupaya mengawal status 
glisemia dan memperbaiki keadaan dislipidemia pada tikus diabetes aruhan 
streptozotocin serta berpotensi mengurangkan komplikasi kardiovaskular akibat diabetes 
melitus. 
 
Kata kunci: Palm vitamin E, diabetes mellitus, hiperglisemia,dislipidemia, komplikasi   
                    kardiovaskular 
 
 
ABSTRACT 
 
In this study,  the effects of palm vitamin E (PV) supplementation on glycemic control and 
lipid profile in diabetic-induce Sprague-Dawley rats have been evaluated.  Diabetes in the 
rats was induced by a single intravenous streptozotocin (50 mg/kg body weight).  The 
diabetic rats were divided into two groups; supplemented with 200 mg/kg body weight/day 
of PV and non-supplemented with PV (No PV group).  Non-diabetic rats (NDM) formed the 
control group and only received saline injection.  After eight weeks of daily 
supplementation, PV significantly lowered the fasting blood glucose (FBG) and 
glycosylated haemoglobin (HbA1c) levels (p<0.01) as compared with No PV group. 
However,  these levels were still significantly higher than the control group (p<0.001).  PV 
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supplementation group also showed significantly lower levels of plasma total cholesterol 
(TC) and low-density lipoprotein cholesterol (LDL-C) (p<0.001) and higher level of high-
density lipoprotein cholesterol (HDL-C) (p<0.001) as compared with No PV group.  In 
conclusion, this study suggested that PV may be effective in controlling glycemic status and 
improving dyslipidemia in streptozotocin-induced diabetic rats and has the potential in 
reducing cardiovascular complication due to diabetes mellitus.  
 
Key words: Palm vitamin E, diabetes mellitus, hyperglycemia, dyslipidemia,   
                  cardiovascular complication 
 
 
 
INTRODUCTION 
 
Diabetes mellitus has been recognized as a main independent risk factor for 
cardiovascular diseases (Klein 1995).  There are 100 million people worldwide with 
diabetes (5% to 8% of overall population), and this number is likely to increase 
significantly in the near future.  Data from clinical studies indicate that most diabetic 
patients die due to cardiovascular diseases, and atherosclerosis accounts for about 8 to 
10% of all diabetic deaths (Gu et al. 1998).  
Diabetes mellitus is a complex, progressive disease, which is accompanied by 
multiple complications.  Hyperglycemia has been accepted as being essential for the 
development of diabetic complications.  Recently, there has been interest in the 
hypothesis that oxidative stress may contribute to the development of complications in 
diabetes mellitus (Bynes 1991).  The oxidative stress is significantly increased in diabetes 
due to prolonged exposure to hyperglycemia.  Chronic hyperglycemia increases the 
generation of free radicals through non-enzymatic glycosylation, glucose autoxidation, 
polyol pathways and reduces the capacities of antioxidant defense system (Giuglioano et 
al. 1996).  
The higher incidence of cardiovascular complication is poorly understood.  Result 
of Diabetes Control and Complication Trial (DCCT) (1993) had established that 
prolonged exposure to hyperglycemia is considered as the primary factor associated with 
the development of diabetic macrovascular complication in type 1 diabetic patients.  The 
DCCT (1993) and The UK Prospective Diabetes Study (Turner et al. 1998) showed that 
the improvement of glycemic control, as measured by reduction in HbA1c levels, 
significantly reduced the risk of development and/or progression of all diabetic 
complications.  DCCT (1993) had also concluded that improving glycemic control would 
reduce the mortality and morbidity due to cardiovascular diseases in type 1 diabetes 
mellitus patients. 
  Dyslipidemia is a primary risk factor for the development of atherosclerosis in 
the general population and diabetes mellitus (Laakso 1995).  Epidemiological surveys 
have shown that total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and 
high-density lipoprotein cholesterol (HDL-C) levels are useful in the assessment of 
cardiovascular risk in diabetic patients.  Dyslipidemia is strongly associated with the 
glycemic control in which, TC, LDL-C and HDL-C levels are usually normal if glycemic 
control is adequate (Laakso 1995). Therefore, it is imperative to correct the glycemic 
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status and dyslipidemia in diabetes mellitus in order to reduce the morbidity and 
mortality rate due to cardiovascular complication. 
Palm vitamin E (PV) is a rich source of vitamin E (having mainly tocotrienol and 
small amount of tocopherol) and an excellent antioxidant.  PV has been used as a 
nutritional supplementation and also has several therapeutic potential benefits (Theriault et 
al. 1999).  Tocotrienol is a fat-soluble vitamin related to the family of tocopherol.  As 
reflected in their structural similarity, tocopherol and tocotrienol are well recognized for 
their antioxidant effect (Kamal-Eldin & Appelqvist 1996).   In general, antioxidants are 
suggested to reduced cardiovascular disease by arresting free radical damage and the usage 
of vitamin E as antioxidant in diabetes mellitus has been extensively studied (Paolisso et al. 
1993).     
Many studies have been carried out to observe the effect of tocopherol on 
cholesterol metabolism but the effect of PV on cholesterol metabolism has received much 
less attention.  There are contradictory reports regarding the effects of PV on serum 
cholesterol levels in man.  Qureshi et al. (1991) and Tan et al. (1991) had reported that PV 
reduced serum TC and LDL-C levels in men whereas Wahlqvist et al. (1992) observed no 
positive reduction in serum TC and LDL-C levels in men after PV administration.  
Therefore, it is necessary to study the effect of PV on cholesterol metabolism in order to 
ascertain whether PV has any effect at all.  In this study the effects of PV on glycemic and 
dyslipidemia were assessed in streptozotocin -induced diabetic rats, in order to obtain more 
information about the potential of PV in reducing the development of diabetic 
cardiovascular complications.  
 
 
MATERIALS AND METHODS 
 
Male Sprague-Dawley rats, (each weighing 260-290 g) were supplied by Animal House of 
Universiti Kebangsaan Malaysia which located at the Institute of Medical Research. The 
rats were housed in plastic containers with floors covered with wood shavings.  Two rats 
were placed in each cage.  The rats were given a standard laboratory diet and water ad 
libitum for eight weeks. PV was supplied by Malaysian Palm Oil Board of Malaysia 
(MPOB).  Diabetes in the rats was induced by a single intravenous streptozotocin (STZ) 
injection (Sigma, St Louis, MO, USA), into tail vein at a dose of 50 mg/kg body weight 
after overnight fasting.  Another group of rats, received saline injection only and formed 
the non-diabetic) group (NDM) 
At day three, diabetic rats with fasting blood glucose levels more than 15 mmol/l 
were selected for the study and divided into two groups: diabetic rats with PV and without 
PV supplementation (No PV).  PV was administered orally at a dose of 200 mg/kg/day, for 
eight weeks. The remaining groups were left untreated. Food and water intake as well as 
body weight were recorded weekly.   
After eight weeks of supplementation, rats were fasted overnight and  blood was 
withdrawn by cardiac puncture under deep anesthesia with diethyl ether.  The blood was 
collected into EDTA tubes and sodium fluoride tube for fasting blood glucose (FBG) 
analysis. The blood sample was centrifuged at 3000 rpm for 7 min at 4°C.  Fasting blood 
glucose (FBG) was measured by glucose-oxidize kits (Trace Scientific, Melbourne, 
Australia. Catalogue no TR 15104) and glycated hemoglobin (HbA1c) was determined by 
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using a method by Eross et al. (1984) and expressed as a % of total hemoglobin. 
Determination of total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) 
was carried using kits (Teco Diagnostics, 1286N. Lakeview Ave. Anaheim) and low-
density lipoprotein cholesterol (LDL-C) determination was calculated using method by 
Friedewald et al. (1972).  
 
STATISTICAL ANALYSIS 
 
All results were expressed as mean ± SEM.  The data were analyzed by one-way analysis 
of variance (ANOVA), followed by post hoc LSD multiple comparison test to estimate the 
significance of different between groups.  The difference between groups was considered 
significant when p< 0.05.  
 
 
RESULTS 
 
The food and water intake of the No PV diabetic group was markedly increased when 
compared with the control group (NDM) (Fig 1 and 2). Food and water intake, although 
expressed per rat, were calculated per cage, so that statistical analysis was not legitimate.  
Figure 1 and 2 show that PV supplementation had considerable effect on water and food 
consumption throughout the study.  Both No PV and PV groups exhibited loss of body 
weight when compared with NDM group at p<0.001.  However PV supplementation 
significantly improved the changes on body weight reduction (P<0.01) compared with No 
PV group (Fig. 3) 
 Fig. 4 and 5 show FBG and HbA1c levels, respectively. All diabetic rats showed 
hyperglycemia throughout the study period.  PV supplementation induced a significant fall 
in FBG and HbA1c levels (p<0.01) in the diabetic rats as compared to No PV diabetic 
group.  Levels of plasma TC, LDL-C and HDL-C are given in Table 1.   Plasma TC and 
LDL-C concentrations were markedly increased in non-supplemented diabetic rats 
(p<0.001) as compared to control.  PV supplementation completely prevented the increase 
of TC and LDL-C and levels were significantly lower compared with the No PV rats 
(P<0.001).  On the other hand the PV supplementation group also has significantly higher 
levels of HDL-C as compared with No PV group (p<0.001).   
 
 
DISCUSSION 
 
Administration of STZ to rats caused destruction of the β cell of pancreas and lead to 
reduction of insulin secretion, leading to increase in plasma glucose levels.  The diabetic 
rats also exhibited increment in food intake due to the failure of the cells to obtain glucose 
as a source of energy.   This may further caused the increment in blood glucose level. 
Consequently, the diabetic rats would get their source of energy from the catabolism of 
protein and fat, which lead to the reduction in body weight.  Hyperglycaemia also leads to 
polyuria and polydipsia.  In this study, all the diabetic rats showed higher levels of 
glycemic status, food and fluid intake as well as decrease in body weight, which also been 
reported by Kocak et al. (2000).  
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After eight weeks of PV supplementation, the glycemic status in streptozotocin-
induced diabetic rats was improved by reducing the levels of FBG and HbA1c.  Improving 
the glycemic status could be the reason for the gain in body weight and decrease in food 
and fluid intake in the PV supplementation rats.  
Vitamin E supplementation has been shown to decrease HbA1c and lipid 
peroxidation in type 1 diabetic patients (Jakus et al. 2000).  The study had also suggested 
that the improvement of glycemic status could be due to the improvement of glucose 
metabolism.  Luostarinen et al. (1995) had reported that supplementation of vitamin E for 
four weeks was capable to prevent hyperglycemia condition following fish oil intake in 
healthy volunteers.   They had also discovered that vitamin E supplementation could 
increase the production of insulin and increase insulin: glucose ratio.  They had postulated 
that the antioxidant effects of vitamin E could have the protective effect to β cell 
destruction, which occurred due to the lipid peroxidation process following the fish oil 
intake.    
Vitamin E supplementation before the induction of diabetes by STZ could prevent 
the destruction of ß cell and also improved the glycemic status in diabetes rats (Ihara et al. 
2000).  The supplementation of PV in our study were started at day 3 of STZ induction. 
Eventhough the destruction of ß cells had occured and caused chronic hyperglycemia, 
further destruction might be prevented by PV probably through its antioxidant mechanism.  
In this study the mechanism of action of PV to improve glycemic status could be due to the 
stimulation of glucose metabolism and also through the antioxidant effects, which 
protected the pancreas from oxidative damage.  
  Recent study has also shown that PV has the potential in improving the oxidative 
stress in diabetic rats (Musalmah et al. 2001).  The study also showed that PV could 
enhance the process of wound healing in diabetic animals, which most probably also 
through the reduction in oxidative stress levels.  
The increase in the glycemic status could probably produce a rise in the values of 
lipid parameters as shown in the non-supplemented diabetic group. The increase in TC and 
LDL-C levels and decrease in HDL-C confirm the dyslipidemia pattern in type 1 diabetes 
mellitus and in agreement with the previous study by Hayashibe et al. (1999).  In an other 
study, HbA1c level was noted as showing positive correlation with TC, LDL-C, 
triglycerides and VLDL-C in diabetes mellitus patients (Ohta et al. 1998).  Thus the data 
obtained from this study support the relationship of poor glycemic control and higher risk 
of cardiovascular complications due to rise in plasma concentrations of TC, LDL-C and 
low concentration of HDL-C.   Therefore, it shows that as the metabolic control of the 
illness worsens, the atherogenic risk increases significantly.   
In this study, non-supplemented diabetic rats showed dyslipidemia, however, PV 
supplementation managed to bring down the levels of TC, LDL-C and increased the level 
of HDL-C.  Therefore by improving the lipid metabolism, PV was able to prevent the 
pathogenesis of cardiovascular complication in diabetes mellitus. 
The data obtained in our study showed PV managed to bring down the atherogenic 
risk due to the significant low levels of TC, LDL-C and significant rise in HDL-C in 
plasma concentration compared to the non-supplemented diabetic group.  As our results 
also demonstrate significantly lower levels of FBG and HbA1c in PV supplemented group 
compared to diabetic group, the improvement of diabetic states could probably cause the 
improvement in the value of lipid parameters. 
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In conclusion, our study showed that PV supplementation could improve the 
glycaemic status and dyslipidemia in streptozotocin induced-diabetic rats and could be used 
in preventing the pathogenesis of atherosclerosis and cardiovascular complications in 
diabetes mellitus. 
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FIGURE 1. Weekly water intake in control (n=7), No PV (n=8) and PV (n=8) groups. 
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FIGURE 2. Weekly food intake in control (n=7), No PV (n=8) and PV 
(n=8) groups. 
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FIGURE 3. Weekly body weight changes in control (n=7), No PV  (n=8) and PV (n=8) 
groups. * P<0.001 vs control; & P<0.01 vs No PV group. 
 
 
 
 
* 
& 
* 
 11 
0
5
10
15
20
25
30
35
Control No PV PV
Groups of study
FB
G
 
(m
m
o
l/l
)
 
 
 
FIGURE 4. FBG levels in the control (n=7), No PV (n=8) and PV (n=8) groups.   * 
P<0.001 vs control group; # P<0.01 vs No PV group. 
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FIGURE 5. Percentage of HbA1c in the control (n=7), No PV (n=8) and PV (n=8) 
groups.   *p<0.001 vs control group; # p<0.01 vs No PV group. 
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TABLE 1.  Levels of TC, LDL-C and HDL-C in control (n =7), No PV (n = 8), and PV 
(n = 8) after eight weeks of study. 
 
 
Lipid Profile (mg/dl) Control No PV PV 
TC 45.59 ± 2.44 72.11 ± 3.50 ∗ 53.38 ± 3.28 &  
LDL-C 18.93 ± 1.01 38.94 ± 3.87 ∗ 14.53 ± 1.18  $ & 
HDL-C 20.84 ± 1.59 4.16 ± 0.58 ∗ 17.67 ± 1.27  $ & 
Values are means ± SEM. ∗ P<0.001 and $ p<0.05 vs control group;   & p<0.001 vs No PV 
group. 
 
 
 
 
 
